Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings (Q38281298)

1 September 2017

1 reference

title

Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings (English)

1 reference

1 September 2017

E Clarke

1

1 reference

1 September 2017

U Desselberger

series ordinal

2

1 reference

1 September 2017

publication date

3 December 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

8

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

1-17

1 reference

Global mortality associated with rotavirus disease among children in 2004.

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Global Illness and Deaths Caused by Rotavirus Disease in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

WHO estimates of the causes of death in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Atomic model of an infectious rotavirus particle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

VP6-sequence-based cutoff values as a criterion for rotavirus species demarcation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Analysis of rotavirus species diversity and evolution including the newly determined full-length genome sequences of rotavirus F and G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Genotype constellation and evolution of group A rotaviruses infecting humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Immunity and correlates of protection for rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Immune responses to rotavirus infection and vaccination and associated correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Analyses of homologous rotavirus infection in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Immunity to rotavirus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Protection from Rotavirus Reinfection: 2-Year Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus infection in infants as protection against subsequent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus within day care centres in Oxfordshire, UK: characterization of partial immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Protective effect of natural rotavirus infection in an Indian birth cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus infection in the neonatal nurseries of a tertiary care hospital in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Whole genome characterization of reassortant G10P[11] strain (N155) from a neonate with symptomatic rotavirus infection: identification of genes of human and animal rotavirus origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus vaccines: recent developments and future considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus immune responses and correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus: to the gut and beyond!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus antigenemia in children is associated with viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Neonatal Rotavirus Infection and Its Relation to Cord Blood Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Immunogenicity of the pentavalent rotavirus vaccine in African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Milk from Brazilian women presents secretory IgA antibodies and neutralizes rotavirus G9P[5].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Neutralizing activity and secretory IgA antibodies reactive with rotavirus SA-11 (serotype G3) in colostrum and milk from Brazilian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Anti-rotavirus antibodies in human milk: quantification and neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus vaccination in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Understanding reduced rotavirus vaccine efficacy in low socio-economic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Efficacy of the oral pentavalent rotavirus vaccine in Mali

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Antibody inhibition of the transcriptase activity of the rotavirus DLP: a structural view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Human Rotavirus VP6-Specific Antibodies Mediate Intracellular Neutralization by Binding to a Quaternary Structure in the Transcriptional Pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

IFN-lambda determines the intestinal epithelial antiviral host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

The battle between rotavirus and its host for control of the interferon signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Membrane vesicles released by intestinal epithelial cells infected with rotavirus inhibit T-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Human myeloid dendritic cells treated with supernatants of rotavirus infected Caco-2 cells induce a poor Th1 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Frequencies of virus-specific CD4(+) and CD8(+) T lymphocytes secreting gamma interferon after acute natural rotavirus infection in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Child undernutrition, tropical enteropathy, toilets, and handwashing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Environmental enteropathy: critical implications of a poorly understood condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Intestinal permeability: update on the enzymatic assay of mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Intestinal permeability, mucosal injury, and growth faltering in Gambian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Intestinal biopsy in kwashiorkor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

An ecological and evolutionary perspective on human-microbe mutualism and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

21 January 2018

Care for the community

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Life, death, and miracles: Th17 cells in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Effector and memory T cell responses to commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Interactions between the microbiota and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Adaptive immunity in the host–microbiota dialog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

The effects of commensal microbiota on immune cell subsets and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Role of the gut microbiota in the development and function of lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

The sensing of environmental stimuli by follicular dendritic cells promotes immunoglobulin A generation in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Infant B cell memory differentiation and early gut bacterial colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Simultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

A naturally processed epitope on rotavirus VP7 glycoprotein recognized by HLA-A2.1-restricted cytotoxic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Global analyses of human immune variation reveal baseline predictors of postvaccination responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Mining the human gut microbiota for effector strains that shape the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Effectiveness of Monovalent Rotavirus Vaccine (Rotarix) against Severe Diarrhea Caused by Serotypically Unrelated G2P[4] Strains in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2014.114

Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FMI.2014.114

21 January 2018

12 December 2020

Escherichia coli in Infants' Intestinal Microflora: Colonization Rate, Strain Turnover, and Virulence Gene Carriage

2 references

https://api.crossref.org/works/10.1038%2FMI.2014.114

21 January 2018

12 December 2020

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

1 reference

12 December 2020

Quantification of systemic and local immune responses to individual rotavirus proteins during rotavirus infection in mice

1 reference

12 December 2020

Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial

1 reference

12 December 2020

Intestinal Colonization with Enterobacteriaceae in Pakistani and Swedish Hospital-Delivered Infants

1 reference

12 December 2020

Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life

1 reference

12 December 2020

Intestinal and serum immune response to a naturally acquired rotavirus gastroenteritis in children.

1 reference

12 December 2020

Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

1 reference

12 December 2020

Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors

1 reference

12 December 2020

Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction

1 reference

12 December 2020

Rotavirus antibodies in the mother and her breast-fed infant

1 reference

12 December 2020

Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.

1 reference

12 December 2020

Effectiveness of pentavalent rotavirus vaccine against severe disease

1 reference

12 December 2020

Neutralizing antibody immune response in children with primary and secondary rotavirus infections

1 reference

12 December 2020

Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children

1 reference

12 December 2020

Human rotavirus specific T cells: quantification by ELISPOT and expression of homing receptors on CD4+ T cells

1 reference

12 December 2020

Rotavirus vaccines:an update

1 reference

12 December 2020

Neonatal Rotavirus Infections

1 reference

12 December 2020

Immune response to rotavirus polypeptides after vaccination with heterologous rotavirus vaccines (RIT 4237, RRV-1)

1 reference

12 December 2020

Serum antibody as a marker of protection against natural rotavirus infection and disease

1 reference

12 December 2020

Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine

1 reference

12 December 2020

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

1 reference

12 December 2020

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR

1 reference

12 December 2020

Rotavirus vaccines. WHO position paper – January 2013

1 reference

12 December 2020

The global burden of diarrhoeal disease in children.

1 reference

12 December 2020

Rotavirus antigenaemia and viraemia: a common event?

1 reference

12 December 2020

Rotavirus fecal IgA antibody response in adults challenged with human rotavirus

1 reference

12 December 2020

Improving the performance of enteric vaccines in the developing world

1 reference

12 December 2020

A TGF-β mediated regulatory mechanism modulates the T cell immune response to rotavirus in adults but not in children

1 reference

12 December 2020

Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life

1 reference

12 December 2020

Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children

1 reference

12 December 2020

Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries

1 reference

12 December 2020

Breast-feeding and the risk of life-threatening rotavirus diarrhea: prevention or postponement?

1 reference

12 December 2020

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children

1 reference

12 December 2020

Acquisition of serum isotype-specific and G type-specific antirotavirus antibodies among children in day care centers

1 reference

12 December 2020

Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group

1 reference

12 December 2020

Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.

1 reference

12 December 2020

Species-specific but not genotype-specific primary and secondary isotype-specific NSP4 antibody responses in gnotobiotic calves and piglets infected with homologous host bovine (NSP4[A]) or porcine (NSP4[B]) rotavirus

1 reference

12 December 2020

Fecal antibody responses to symptomatic and asymptomatic rotavirus infections

1 reference

12 December 2020

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

1 reference

12 December 2020

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

1 reference

12 December 2020

Serum antibody responses to individual viral polypeptides in human rotavirus infections

1 reference

12 December 2020

Serum rotavirus neutralizing-antibody titers compared by plaque reduction and enzyme-linked immunosorbent assay-based neutralization assays

1 reference

12 December 2020

Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua

1 reference

12 December 2020

Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988-1999

1 reference

12 December 2020

Asymptomatic environmental enteropathy among slum-dwelling infants

1 reference

12 December 2020

Role of coproantibody in clinical protection of children during reinfection with rotavirus

1 reference

12 December 2020

Identifiers

DOI

10.1038/MI.2014.114

1 reference

Dimensions Publication ID

1 September 2017

1045236690

0 references

1 reference